Browse the evidence

The only inflammatory biomarker that seems to be associated with the vegetarian diet was inflammatory mediator C-reactive protein, which in several studies showed lower values in vegetarians as compared to omnivores.

Monitoring C-reactive protein levels may be beneficial for vegetarians.

Continuous glucose monitoring can be used to detect early dysglycemia in individuals with elevated glucose levels.

Practitioners can integrate continuous glucose monitoring into clinical practice to identify prediabetes.

Early detection of dysglycemia can be integrated into clinical practice settings.

Clinicians can adopt continuous glucose monitoring to enhance early detection of dysglycemia.

Lean Six Sigma was used in a quality improvement effort to design a method for physicians to prescribe health coaching for healthy behaviors.

Practitioners can implement health coaching as part of patient care using structured methodologies like Lean Six Sigma.

A high body mass index is one of the strongest risk factors for new-onset chronic kidney disease.

Monitoring BMI can be crucial for kidney health assessments.

Obesity and overweight are linked to a higher risk of asthma.

Practitioners should consider weight management as a factor in asthma risk.

Acai supplementation increased Trolox-equivalent antioxidant capacity (TEAC) by 11% after 24 hours compared to placebo.

Acai supplementation may enhance antioxidant capacity in men post-exercise.

A high body mass index is one of the strongest risk factors for new-onset Chronic Kidney Disease.

Monitoring BMI can be crucial in preventing Chronic Kidney Disease.

Rapid weight loss leads to dehydration in MMA athletes.

Athletes should be aware of the risks of dehydration when engaging in rapid weight loss.

Diabetic nephropathy significantly increases cardiovascular risk.

Monitoring cardiovascular health is crucial for T2D patients with diabetic nephropathy.

The Open Formulary group had a mean reduction in A1c of −2.7 ± 2.4, which was significantly greater than the Restrictive Formulary group's reduction of −0.74 ± 2.1.

Practitioners may consider that an open formulary can lead to better glycemic control in patients with type 2 diabetes.

The association between adiposity and cardiovascular events is linear above specific BMI thresholds.

Understanding BMI thresholds can help in assessing cardiovascular risk.

Gastrointestinal adverse events were more frequent with semaglutide (82.8%) compared to placebo (63.2%).

Clinicians should monitor for gastrointestinal side effects when prescribing semaglutide.

The most common adverse events with tirzepatide were gastrointestinal, primarily mild to moderate in severity.

Practitioners should monitor for gastrointestinal side effects in patients using tirzepatide.

Gastrointestinal adverse events were reported in 79.6% of the cagrilintide-semaglutide group and 39.9% in the placebo group.

Clinicians should monitor for gastrointestinal side effects in patients receiving cagrilintide-semaglutide.

Gastrointestinal adverse events were more common with oral semaglutide than with placebo (74.0% vs. 42.2%).

Clinicians should monitor for gastrointestinal side effects in patients taking oral semaglutide.

Gastrointestinal adverse effects were the most commonly reported side effects of retatrutide.

Clinicians should monitor for gastrointestinal side effects in patients treated with retatrutide.

The most common adverse events in the retatrutide groups were gastrointestinal and were mostly mild to moderate in severity.

Practitioners should monitor for gastrointestinal side effects in patients treated with retatrutide.

Moderate weight gain is associated with lower odds of achieving a composite healthy aging outcome.

Weight management strategies may be crucial for promoting healthy aging.

About 14% caloric restriction for 2 years in healthy humans improved thymopoiesis.

Caloric restriction may enhance immune function in healthy individuals.

Resmetirom achieved resolution of steatohepatitis without worsening of fibrosis in 26%-30% of participants compared to 10% for placebo.

Resmetirom may be an effective treatment option for patients with MASH and moderate to advanced liver fibrosis.

Resmetirom improved fibrosis without worsening of steatohepatitis in 24%-26% of participants compared to 14% for placebo.

Resmetirom may help improve liver fibrosis in patients with MASH without worsening their condition.

There was no significant effect of whey or soy alone on LBM change.

Neither whey nor soy protein alone is effective for increasing LBM.

No significant changes in quadriceps cross-sectional area were observed in the low-load not to failure group.

Avoid low-load training without reaching muscle failure if hypertrophy is the goal.